BioArctic, Eli Lilly ink deal to combine drug-delivery tech with Lilly compound

Investing.com Gold reports: BioArctic, Eli Lilly ink deal to combine drug-delivery tech with Lilly compound. Full body text was unavailable at ingest time, so this brief is based on headline context.